European Federation of Biotechnology - PDFSEARCH.IO - Document Search Engine

European Federation of Biotechnology
Results: 69

#	Item
1	European Federation of Biotechnology - Microbial Physiology Section Open meeting of the section during the 2nd Microbial Stress meeting in Belgirate, Italy at 17:30, May 12, 2012. Attendees: Aertsen Abram, Branduardi Pao Add to Reading List Source URL: efb-central.org - Date: 2012-05-21 05:44:40
2	• • a European Federation of Biotechnology event incorporating Eurobiotech Add to Reading List Source URL: www.cr-hana.eu - Date: 2016-03-15 11:17:00
3	European Federation of Biotechnology Microbial Physiology Section Open Meeting of the Section during the 6th Recombinant Protein Production meeting in Vienna ath on Friday, 18th FebruaryAttendees: Add to Reading List Source URL: efb-central.org - Date: 2011-11-25 09:20:09
4	European Federation of Biotechnology Microbial Physiology Section The Open Meeting of the Section was held at Porto Conte Ricerche Srl, S.P. 55 Porto Conte/Capo Caccia during the Fifth Recombinant Protein Production meet Add to Reading List Source URL: efb-central.org Language: English - Date: 2011-11-25 09:20:11 Parliamentary procedure Biotechnology European Federation of Biotechnology British Science Association Meeting Science and technology Europe United Kingdom
5	European Federation of Biotechnology Microbial Physiology Section The 2007 Annual meeting of the EFB Microbial Physiology Section was held aton Monday 17th September during ECB13, Fira de Barcelona in Barcelona, Add to Reading List Source URL: efb-central.org Language: English - Date: 2011-11-25 09:20:11 Biotechnology Economy European Federation of Biotechnology Science and technology Technology Meeting European Federation of Pharmaceutical Industries and Associations British Science Association Medicon Valley
6	ABIRISK ABIRISK Project Officially Started A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments for Add to Reading List Source URL: www.abirisk.eu Language: English - Date: 2012-06-04 10:07:55 Pharmaceutical sciences Pharmacology Business Pharmaceutical industry Pharmacy Biotechnology European Federation of Pharmaceutical Industries and Associations Immunogenicity Drug discovery Novartis Biopharmaceutical Sanofi
7	Microsoft Word - Minutes MP, Marchdoc Add to Reading List Source URL: efb-central.org Language: English - Date: 2013-06-19 07:27:21 Biotechnology European Federation of Biotechnology Physiology Meeting
8	EFB Microbial Physiology Section A meeting of the EFB Microbial Physiology Section was held at 17:50 h on Friday , May 27, 2005 during the 3rd Meeting on Analysis of Microbial Cells at the Single Cell Level in the Hotel Add to Reading List Source URL: efb-central.org Language: English - Date: 2011-11-25 09:20:05 Biotechnology Biology Nature European Federation of Biotechnology Physiology Recombinant DNA Protein production Federation of European Microbiological Societies Expression vector
9	The Animal Task Force (ATF) promotes a sustainable and competitive animal production in Europe. We are a public private partnership of experts from knowledge institutes and industry representative organisations from acro Add to Reading List Source URL: www.animaltaskforce.eu Language: English - Date: 2016-08-09 03:25:52 Biobased economy Biotechnology Animal European Federation of Animal Science Sustainability Livestock Bureau of Alcohol Tobacco Firearms and Explosives
10	ABIRISK Making novel drugs safer for patients A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments Add to Reading List Source URL: www.abirisk.eu Language: English - Date: 2012-11-23 07:10:19 Pharmaceutical industry Pharmacy Pharmaceuticals policy Biotechnology Immunogenicity Immunology European Federation of Pharmaceutical Industries and Associations Biopharmaceutical Novartis Sanofi Pharmaceutical drug Drug development

UPDATE